Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 11, 2014, Pages 1316-1318

  Kelly, J Daniel ^a   Lin, Shou Yean Grace ^b   Barry, Pennan M ^b   Keh, Chris ^a,c   Higashi, Julie ^a,c   Metcalfe, John Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGED; ANTIBIOTIC RESISTANCE; CASE REPORT; CHINA; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DYSPNEA; HUMAN; ISOLATION AND PURIFICATION; LUNG; MALE; MICROBIOLOGY; MIGRANT; MYCOBACTERIUM TUBERCULOSIS; PATHOLOGY; PLEURAL EFFUSION; PREDICTIVE VALUE; RADIOGRAPHY; RECURRENT DISEASE; SPUTUM; TUBERCULOSIS, PULMONARY; UNITED STATES;

AGED; ANTIBIOTICS, ANTITUBERCULAR; CHINA; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, BACTERIAL; DYSPNEA; EMIGRANTS AND IMMIGRANTS; HUMANS; LUNG; MALE; MYCOBACTERIUM TUBERCULOSIS; PLEURAL EFFUSION; PREDICTIVE VALUE OF TESTS; RECURRENCE; RIFAMPIN; SAN FRANCISCO; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, PULMONARY;

EID: 84916217895     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201408-1500LE     Document Type: Letter

References (14)

1. Lin SY, Rodwell TC, Victor TC, Rider EC, Pham L, Catanzaro A, Desmond EP. Pyrosequencing for rapid detection of extensively drugresistant Mycobacteria tuberculosis in clinical isolates and clinical specimens. J Clin Microbiol 2014;52:475-482.
2. Porco TC, Oh P, Flood JM. Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006. Clin Infect Dis 2013;56:761-769.
3. World Health Organization. Global tuberculosis report 2014 [accessed 2014 Nov 14]. Available from: http://www.who.int/tb/publications/global-report/en/
4. Hsu AH, Lee JJ, Chiang CY, Li YH, Chen LK, Lin CB. Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan. Int J Tuberc Lung Dis 2013;17:354-356.
5. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005;60:130-135.
6. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, nearpatient technology. J Clin Microbiol 2010;48:229-237.
7. Van Rie A, Mellet K, John MA, Scott L, Page-Shipp L, Dansey H, Victor T, Warren R. False-positive rifampicin resistance on Xpert MTB/RIF: case report and clinical implications. Int J Tuberc Lung Dis 2012;16:206-208.
8. Kennedy N, Gillespie SH, Saruni AO, Kisyombe G, McNerney R, Ngowi FI, Wilson S. Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. J Infect Dis 1994;170:713-716.
9. Friedrich SO, Rachow A, Saathoff E, Singh K, Mangu CD, Dawson R, Phillips PP, Venter A, Bateson A, Boehme CC, et al .; Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics (PanACEA). Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med 2013;1:462-470.
10. Boyles TH, Hughes J, Cox V, Burton R, Meintjes G, Mendelson M. False-positive Xpert() MTB/RIF assays in previously treated patients: need for caution in interpreting results. Int J Tuberc Lung Dis 2014;18:876-878.
11. World Health Organization. Xpert MTB/RIF implementation manual. Technical and operational 'how-to': practical considerations. Geneva, Switzerland: World Health Organization; 2014 [accessed 2014 Oct 6]. Available from: http://apps.who.int/iris/bitstream/10665/112469/1/9789241506700-eng.pdf
12. Jureen P, Engstrand L, Eriksson S, Alderborn A, Krabbe M, Hoffner SE. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol 2006;44:1925-1929.
13. Lippincott CK, Miller MB, Popowitch EB, Hanrahan CF, Van Rie A. Xpert(R) MTB/RIF shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States. Clin Infect Dis 2014;59:186-192.
14. Centers for Disease C. Prevention. Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013. MMWR Morb Mortal Wkly Rep 2013;62:821-827.